EUVIMEDEUVIMED entdecken
Open Access

Post‐ COVID ‐19 inflammation and sarcopenia in obese diabetic dialysis patients

Carlos Alexandre Ferreira de Oliveira iD, Livia Maria Borges Amaral iD, José Pedro Cassemiro Micheleto iD, Karin Araujo Melo iD, Mateus de Medeiros Rijo iD, Pedro Gustavo Barbosa Lira iD, Emiliano de Oliveira Barreto iD, Juliane Pereira da Silva iD, Antônio Filipe Pereira Caetano iD, Juliana Célia de Farias Santos iD, Michelle Jacintha Cavalcante Oliveira iD

Therapeutic Apheresis and Dialysis · 2026

DOI: 10.1111/1744-9987.14237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2026. Verfasst von Carlos Alexandre Ferreira de Oliveira und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Federal University of Alagoas, Maceió, Brazil. Hauptthemen laut MEDLINE: Sarcopenia, Inflammation, Renal Dialysis, Obesity. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundação de Amparo à Pesquisa do Estado de Alagoas, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Diabetes, obesity, and CKD collectively impact musculoskeletal health and increase the risk of severe coronavirus disease 2019 (COVID‐19) outcomes.

Methods

This cross‐sectional study included 32 dialysis patients, categorized based on their COVID‐19 status. Laboratory assessments included inflammatory markers (IL‐1β, IL‐6, IL‐8, and TNF‐α). Sarcopenia risk was evaluated using the strength, assistance with walking, rising from a chair, climbing stairs, and falls (SARC‐F) questionnaire, bioimpedance analysis, and static muscle strength testing.

Results

No significant differences were observed between groups in laboratory values, sarcopenia risk, or inflammatory markers. Body composition, SARC‐F scores, and static muscle strength were comparable across both groups, except for elevated parathyroid hormone (PTH) levels in Group A ( p = 0.008).

Conclusion

The lack of association between the inflammatory response and sarcopenia risk may be attributed to the existing inflammatory status of this population, given the coexistence of diabetes, CKD, and obesity. Notably, all studied laboratory variables showed no significant differences, except for the higher PTH levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaInflammationRenal DialysisObesityCOVID-19Renal Insufficiency, ChronicHumansCross-Sectional StudiesFemaleMaleMiddle AgedAgedMuscle StrengthRisk Factors

Stichwörter der Autor:innen

COVID‐19chronic kidney diseasediabetes mellitushemodialysisinflammationobesity

Autor:innen und Institutionen

  • Faculty of Medicine, Federal University of Alagoas, Maceió, Brazil.
  • Institute of Biological Science, Federal University of Alagoas, Maceió, Brazil.
  • Institute of Physical Education and Sports, Federal University of Alagoas, Maceió, Brazil.
  • Faculty of Nutrition, Federal University of Alagoas, Maceió, Brazil.

ORCID-Profile: Carlos Alexandre Ferreira de Oliveira, Livia Maria Borges Amaral, José Pedro Cassemiro Micheleto, Karin Araujo Melo, Mateus de Medeiros Rijo, Pedro Gustavo Barbosa Lira, Emiliano de Oliveira Barreto, Juliane Pereira da Silva, Antônio Filipe Pereira Caetano, Juliana Célia de Farias Santos, Michelle Jacintha Cavalcante Oliveira

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Alagoas
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

de Oliveira, C. A. F., Amaral, L. M. B., Micheleto, J. P. C., Melo, K. A., de Medeiros Rijo, M., Lira, P. G. B., de Oliveira Barreto, E., da Silva, J. P., Caetano, A. F. P., de Farias Santos, J. C., & Oliveira, M. J. C. (2026). Post‐ COVID ‐19 inflammation and sarcopenia in obese diabetic dialysis patients. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14237

Vancouver

de Oliveira CAF, Amaral LMB, Micheleto JPC, Melo KA, de Medeiros Rijo M, Lira PGB, et al. Post‐ COVID ‐19 inflammation and sarcopenia in obese diabetic dialysis patients. Therapeutic Apheresis and Dialysis. 2026. doi:10.1111/1744-9987.14237

BibTeX
@article{deOliveira2026,
  author = {de Oliveira, Carlos Alexandre Ferreira and Amaral, Livia Maria Borges and Micheleto, José Pedro Cassemiro and Melo, Karin Araujo and de Medeiros Rijo, Mateus and Lira, Pedro Gustavo Barbosa and de Oliveira Barreto, Emiliano and da Silva, Juliane Pereira and Caetano, Antônio Filipe Pereira and de Farias Santos, Juliana Célia and Oliveira, Michelle Jacintha Cavalcante},
  title = {Post‐ COVID ‐19 inflammation and sarcopenia in obese diabetic dialysis patients},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2026},
  doi = {10.1111/1744-9987.14237}
}
Kostenlos starten →